content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001302110</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001674930</issuerCik>
  <issuerName>FULGENT GENETICS, INC.</issuerName>
  <secFileNumber>001-37894</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">4399 Santa Anita Ave</street1>
  <city xmlns="http://www.sec.gov/edgar/common">El Monte</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">91731</zipCode>
  </issuerAddress>
  <issuerContactPhone>626-350-0537</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Hsieh Ming </nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Owner</relationshipToIssuer>
  <relationshipToIssuer>Officer</relationshipToIssuer>
  <relationshipToIssuer>Director</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>Morgan Stanley Smith Barney LLC</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">1 New York Plaza, 38th FL</street1>
  <city xmlns="http://www.sec.gov/edgar/common">New York</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">10004</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>2313</noOfUnitsSold>
  <aggregateMarketValue>52812.84</aggregateMarketValue>
  <noOfUnitsOutstanding>30296682</noOfUnitsOutstanding>
  <approxSaleDate>08/27/2024</approxSaleDate>
  <securitiesExchangeName>NASDAQ</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <acquiredDate>02/23/2023</acquiredDate>
  <natureOfAcquisitionTransaction>Resticted stock vest</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Fulgent Genetics, Inc.</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>47393</amountOfSecuritiesAcquired>
  <paymentDate>02/23/2023</paymentDate>
  <natureOfPayment>Equity compensation for services rendered</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <remarks>Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. </remarks>
  <noticeSignature>
  <noticeDate>08/27/2024</noticeDate>
  <signature>/s/ Paul Kim as Attorney-in-Fact</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3125}]
text: 144
  0001302110
  XXXXXXXX
  LIVE
  0001674930
  FULGENT GENETICS, INC.
  001-37894
  4399 Santa Anita Ave
  El Monte
  CA
  91731
  626-350-0537
  Hsieh Ming
  Owner
  Officer
  Director
  Common Stock
  Morgan Stanley Smith Barney LLC
  1 New York Plaza, 38th FL
  New York
  NY
  10004
  2313
  52812.84
  30296682
  08/27/2024
  NASDAQ
  Common Stock
  02/23/2023
  Resticted stock vest
  Fulgent Genetics, Inc.
  N
  47393
  02/23/2023
  Equity compensation for services rendered
  Y
  Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  08/27/2024
  /s/ Paul Kim as Attorney-in-Fact